Abstract
Gastrointestinal manifestations are common in systemic lupus erythematosus (SLE). Intestinal pseudo-obstruction (IpO) is a rare, poorly understood and recently recognized gastrointestinal manifestation of SLE. We report a 26-year-old female with SLE for 3 years. 10 months ago, IpO was diagnosed first, and it was responded well to high-dose steroid therapy. After then, oral prednisolone and azathioprine were administered, but the patient had been lost to follow up until recurrence of IpO. She was admitted with diffuse abdominal pain, distension, frequent vomiting, and intermittent dysuria due to recurrent IpO accompanied with bilateral ureterohydronephrosis. Despite of high dose steroid therapy, her symptom and imaging findings were not improved. The patient was treated with pulses of cyclophosphamide, and then the patient's symptoms and signs were gradually subsided. Three weeks following cyclophosphamide therapy, she was able to eat without vomiting and following abdominal CT showed nearly complete resolution of diffuse intestinal distension and bilateral ureterohydronephrosis. High level of awareness of IpO in SLE and appropriate medical treatment is needed to prevent unnecessary surgical treatment. And if this complication is refractory to corticosteroid, active immunosuppressive therapy, such as cyclophosphamide, should be considered.
References
1. Stanghellini V, Cogliandro RF, de Giorgio R, Barbara G, Salvioli B, Corinaldesi R. Chronic intestinal pseudoobstruction: manifestations, natural history and management. Neurogastroenterol Motil. 2007; 19:440–52.
2. Narvaez J, Perez-Vega C, Castro-Bohorquez FJ, Garcia-Quintana AM, Biosca M, Vilaseca-Momplet J. Intestinal pseudoobstruction in systemic lupus erythematosus. Scand J Rheumatol. 2003; 32:191–5.
3. Shamberger RC, Crawford JL, Kirkham SE. Progressive systemic sclerosis resulting in megacolon. A case report. JAMA. 1983; 250:1063–5.
4. Stafford-Brady FJ, Kahn HJ, Ross TM, Russell ML. Advanced scleroderma bowel: complications and management. J Rheumatol. 1988; 15:869–74.
5. 김채기, 류헌모, 권중구, 이창형, 송용호, 최정윤. Systemic sclerosis sine scleroderma 1예. 대한류마티스학회 지. 2000; 7:313–8.
6. Marshall JB, Kretschmar JM, Gerhardt DC, Winship DH, Winn D, Treadwell EL, et al. Gastrointestinal manifestations of mixed connective tissue disease. Gastroenterology. 1990; 98:1232–8.
7. Kleckner FS. Dermatomyositis and its manifestations in the gastrointestinal tract. Am J Gastroenterol. 1970; 53:141–6.
8. Cacoub P, Benhamou Y, Barbet P, Piette JC, Le Cae A, Chaussade S, et al. Systemic lupus erythematosus and chronic intestinal pseudoobstruction. J Rheumatol. 1993; 20:377–81.
9. Hill PA, Dwyer KM, Power DA. Chronic intestinal pseudoobstruction in systemic lupus erythematosus due to intestinal smooth muscle myopathy. Lupus. 2000; 9:458–63.
10. Mok MY, Wong RW, Lau CS. Intestinal pseudoobstruction in systemic lupus erythematosus: an uncommon but important clinical manifestation. Lupus. 2000; 9:11–8.
11. 안중경, 고재현, 전찬홍, 차훈석, 김영호, 고은미. 전신 성 홍반성 루푸스에서의 위장관 가성폐색증 1예. 대 한류마티스학회지. 2002; 9:313–8.
12. Alexopoulou A, Andrianakos A, Dourakis SP. Intestinal pseudoobstruction and ureterohydronephrosis as the presenting manifestations of relapse in a lupus patient. Lupus. 2004; 13:954–6.